- Conformis Inc (NASDAQ:CFMS) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient’s membership of healthcare facilities.
- The agreement gives increased access to the entire Conformis knee and hip portfolio to Vizient’s membership base, which comprises academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute health care providers.
- The offering includes:
- Identity Imprint, a personalized knee replacement system.
- Image-to-Implant Platinum Services Program, a patient-elected deluxe upgrade option to obtain a fully personalized knee replacement implant.
- Cordera Match Hip System, a personalized primary hip replacement solution.
- Researchers at the University of Washington in Seattle found that fully personalized total knee arthroplasty is cost-effective compared to a standard, off-the-shelf implant.
- Ongoing research suggests that fully personalized implants further reduce total costs to the healthcare system because patients recover more quickly and are less likely to require follow-up corrective (revision) surgeries.
- Price Action: CFMS shares are up 4.31% at $0.27 during the premarket session on the last check Tuesday.
Blue Bird Appoints Head Of Electric Vehicle Business, Britton Smith To Company President, Effective July 1, 2023
Blue Bird Corporation (NASDAQ:BLBD), the leader in electric and low-emission school buses, today announced the appointment of Britton Smith to president, effective July 1, 2023. Phil Horlock, Blue Bird president and CEO,
